Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Glaxo's Avandia Should Be Pulled From U.K. Market, BMJ Chief Editor Says
Glaxo's Avandia Should Be Pulled From U.K. Market, BMJ Chief Editor Says
Glaxo's Avandia Should Be Pulled From U.K. Market, BMJ Chief Editor Says
Submitted by
admin
on September 6, 2010 - 10:11am
Source:
Bloomberg
News Tags:
GSK
Avandia
diabetes
Bristol-Myers Squibb
Headline:
Glaxo's Avandia Should Be Pulled From U.K. Market, BMJ Chief Editor Says
Do Not Allow Advertisers to Use My Personal information
